Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
15.05. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 15.05.2025 | 666 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 15.05.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 15.05.2025.ISIN NameCA05259R1073 AUSTRALIS... ► Artikel lesen | |
15.05. | Alliance Pharma PLC - Cancellation of Trading | 1 | RNS | ||
15.05. | AIM - Cancellation - Alliance Pharma Plc | - | RNS | ||
14.05. | AIM - Suspension - Alliance Pharma plc | 1 | RNS | ||
14.05. | Alliance Pharma PLC - Scheme of Arrangement Becomes Effective | 1 | RNS | ||
ALLIANCE PHARMA Aktie jetzt für 0€ handeln | |||||
14.05. | XFRA DVL: AUSSETZUNG/SUSPENSION | 283 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILALLIANCE PHARMA... ► Artikel lesen | |
13.05. | XFRA CAPITAL ADJUSTMENT INFORMATION - 13.05.2025 | 699 | Xetra Newsboard | Das Instrument ZRE CH0042615283 DOCMORRIS AG SF 30 EQUITY wird ex Kapitalmassnahme gehandelt am 13.05.2025 The instrument ZRE CH0042615283 DOCMORRIS AG SF 30 EQUITY is traded ex capital adjustment on... ► Artikel lesen | |
12.05. | Alliance Pharma PLC - COURT SANCTION OF THE SCHEME OF ARRANGEMENT | - | RNS | ||
09.05. | FTSE Russell - Alliance Pharma: Constituent Deletion - Changes in FTSE UK Index Series | - | RNS | ||
01.05. | Alliance Pharma PLC - Notification of Major Holdings | - | RNS | ||
30.04. | INVESTEC BANK PLC: Form 8.5 (EPT/RI) - Alliance Pharma plc | 1 | GlobeNewswire (USA) | ||
29.04. | Alliance Pharma PLC - Notification of Major Holdings | - | RNS | ||
25.04. | INVESTEC BANK PLC: Form 8.5 (EPT/RI) - Alliance Pharma plc | 1 | GlobeNewswire (USA) | ||
23.04. | Alliance Pharma director plans share acquisition | 2 | Investing.com | ||
23.04. | Alliance Pharma PLC - Director's intention to acquire shares | - | RNS | ||
17.04. | INVESTEC BANK PLC: Form 8.5 (EPT/RI) - Alliance Pharma plc | 1 | GlobeNewswire (USA) | ||
10.03. | Samson Rock Capital LLP - Form 8.3 - Alliance Pharma Plc | 236 | PR Newswire | Samson Rock Capital LLP - Form 8.3 - Alliance Pharma Plc
PR Newswire
LONDON, United Kingdom, March 10
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY... ► Artikel lesen | |
07.03. | Samson Rock Capital LLP - Form 8.3 - Alliance Pharma Plc | 257 | PR Newswire | Samson Rock Capital LLP - Form 8.3 - Alliance Pharma Plc
PR Newswire
LONDON, United Kingdom, March 07
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY... ► Artikel lesen | |
06.03. | Samson Rock Capital LLP - Form 8.3 - Alliance Pharma Plc | 216 | PR Newswire | Samson Rock Capital LLP - Form 8.3 - Alliance Pharma Plc
PR Newswire
LONDON, United Kingdom, March 06
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY... ► Artikel lesen | |
04.03. | Samson Rock Capital LLP - Form 8.3 - Alliance Pharma Plc | 273 | PR Newswire | Samson Rock Capital LLP - Form 8.3 - Alliance Pharma Plc
PR Newswire
LONDON, United Kingdom, March 04
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
NOVO NORDISK | 50,40 | -0,77 % | UBS stuft NOVO NORDISK auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Novo Nordisk mit einem Kursziel von 340 dänischen Kronen auf "Neutral" belassen. Matthew Weston wertete am Freitag die wöchentlichen... ► Artikel lesen | |
PFIZER | 21,680 | -0,69 % | Bellevue Asset Management: Pfizer-Trump-Vereinbarung stellt Wendepunkt in der Debatte um Arzneimittelpreise dar | Von Dr. Terence McManus, Senior Healthcare Portfolio Manager bei Bellevue Asset Management Pfizer ergreift erste Massnahmen, um Investoren die nötige Sicherheit für den Sektor zu gebenPfizer und Präsident... ► Artikel lesen | |
SANOFI | 83,93 | -1,13 % | UBS stuft SANOFI auf 'Buy' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat das Kursziel für Sanofi von 115 auf 105 Euro gesenkt, aber die Einstufung auf "Buy" belassen. Analyst Matthew Weston geht laut seinem Ausblick... ► Artikel lesen | |
GSK | 18,855 | -0,32 % | JPMORGAN stuft GSK auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für GSK mit einem Kursziel von 1400 Pence auf "Underweight" belassen. Im Fokus stehe zunächst die Zulassungsentscheidung für das... ► Artikel lesen | |
INCYTE | 73,66 | +0,46 % | What 14 Analyst Ratings Have To Say About Incyte | ||
IONIS PHARMACEUTICALS | 60,60 | -0,33 % | Ionis Pharmaceuticals stock maintains Buy rating at TD Cowen on pipeline strength | ||
CSPC PHARMA | 1,042 | +0,97 % | CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - SYH2070 INJECTION (A DOUBLE-STRANDED SMALL INTERFERING RNA DRUG) OBTAINS CLINICAL TRIAL APPROVAL IN THE ... | ||
ALNYLAM PHARMACEUTICALS | 394,10 | -0,28 % | H.C. Wainwright bestätigt Kaufempfehlung für Alnylam: Neue FDA-Richtlinien als Kurstreiber | ||
SELLAS LIFE SCIENCES | 1,658 | +1,10 % | SELLAS Life Sciences Group, Inc. - 8-K, Current Report | ||
ACADIA PHARMACEUTICALS | 17,965 | +0,62 % | Mizuho maintains Neutral rating on Acadia Pharmaceuticals stock ahead of Q3 | ||
TRULIEVE CANNABIS | 7,280 | -6,06 % | Trulieve Cannabis Corp.: Trulieve Announces Appointment of Board Member Matthew Foulston and Chief Financial Officer Jan Reese | TALLAHASSEE, Fla., Aug. 27, 2025 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing... ► Artikel lesen | |
CATALYST PHARMACEUTICALS | 18,000 | -0,14 % | Catalyst Pharmaceuticals, Inc.: Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE (amifampridine) Patent Litigation with Lupin Pharmaceuticals | CORAL GABLES, Fla., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing... ► Artikel lesen | |
MADRIGAL PHARMACEUTICALS | 362,20 | -2,19 % | Madrigal Pharmaceuticals, Inc.: Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) | CONSHOHOCKEN, Pa., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated... ► Artikel lesen | |
WEST PHARMACEUTICAL SERVICES | 230,30 | +0,96 % | West Pharmaceutical Services' Quarterly Earnings Preview: What You Need to Know | ||
ENZON PHARMACEUTICALS | 0,058 | 0,00 % | Enzon Pharmaceuticals, Inc: Enzon and Viskase Enter into Merger Agreement | CRANFORD, N.J. and LOMBARD, Ill., June 20, 2025 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQX: ENZN) ("Enzon" or the "Company") and Viskase Companies, Inc. (OTC Pink Limited: VKSC) ("Viskase")... ► Artikel lesen |